Vaccination of endangered wildlife as a conservation tool: Hindsights and new horizons in the pandemic era

Vaccines are an established conservation tool that can reduce the threat of infectious disease in endangered wildlife populations. Vaccines exist for many infectious pathogens, and at a time of rapid technological advances in vaccinology, developing vaccines and vaccination programs for free-living endangered wildlife could help efforts to prevent extinctions from disease threats. Vaccination efforts could focus on protecting members of the target species or could be directed at reservoir populations to prevent pathogen spillover. Vaccination strategies need to be substantiated by research on safety and effectiveness, include risk and feasibility assessments, account for differences in host biology and disease epidemiology, and align with relevant regulatory frameworks. Engagement with stakeholders and the public is important to ensure the success of endangered species vaccination programs. Challenges such as funding, regulation, and societal acceptance are barriers to progress in vaccination programs for some species and geographic regions. We recommend the development of scientifically based international guidelines and a transdisciplinary forum with a specific emphasis on endangered wildlife vaccination. New technologies could be used collaboratively to prevent transmission of diseases for which vaccines are not currently available. Careful approaches and enhanced collaborations could help ensure the successful development of wildlife vaccination programs and promote resilience of endangered wildlife populations to increasing anthropogenic and environmental stressors on biodiversity. • Vaccines can protect rare species from diseases which pose a risk of extinction. • Safe delivery of vaccines to wildlife requires knowledge of host biology and ecology. • Challenges include lack of funding, regulatory concerns, and societal acceptance. • Public support helps ensure success of wildlife vaccination and conservation. • International guidelines could provide a framework for vaccination of rare species.

Authors

Institutions

Publication Details

Journal
Biological Conservation
Published
2024-11-11
DOI
https://doi.org/10.1016/j.biocon.2024.110842
Citations
6
Primary Topic
Zoonotic diseases and public health
Type
article
Field-Weighted Citation Impact
3.26
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Vaccination of endangered wildlife as a conservation tool: Hindsights and new horizons in the pandemic era

Tonie E. Rocke, A. Hall, Frances M. D. Gulland, Sarah Cleaveland et al.
6 citations
Biological Conservation
Zoonotic diseases and public health
3.26
article

Vaccination of endangered wildlife as a conservation tool: Hindsights and new horizons in the pandemic era

Tonie E. Rocke, A. Hall, Frances M. D. Gulland, Sarah Cleaveland, Martin Gilbert, Michelle Barbieri
article en
6 citations

Abstract

Vaccines are an established conservation tool that can reduce the threat of infectious disease in endangered wildlife populations. Vaccines exist for many infectious pathogens, and at a time of rapid technological advances in vaccinology, developing vaccines and vaccination programs for free-living endangered wildlife could help efforts to prevent extinctions from disease threats. Vaccination efforts could focus on protecting members of the target species or could be directed at reservoir populations to prevent pathogen spillover. Vaccination strategies need to be substantiated by research on safety and effectiveness, include risk and feasibility assessments, account for differences in host biology and disease epidemiology, and align with relevant regulatory frameworks. Engagement with stakeholders and the public is important to ensure the success of endangered species vaccination programs. Challenges such as funding, regulation, and societal acceptance are barriers to progress in vaccination programs for some species and geographic regions. We recommend the development of scientifically based international guidelines and a transdisciplinary forum with a specific emphasis on endangered wildlife vaccination. New technologies could be used collaboratively to prevent transmission of diseases for which vaccines are not currently available. Careful approaches and enhanced collaborations could help ensure the successful development of wildlife vaccination programs and promote resilience of endangered wildlife populations to increasing anthropogenic and environmental stressors on biodiversity. • Vaccines can protect rare species from diseases which pose a risk of extinction. • Safe delivery of vaccines to wildlife requires knowledge of host biology and ecology. • Challenges include lack of funding, regulatory concerns, and societal acceptance. • Public support helps ensure success of wildlife vaccination and conservation. • International guidelines could provide a framework for vaccination of rare species.

Biological ConservationVol. 300
University of St Andrews (GB), Cornell University (US), NOAA National Marine Fisheries Service Pacific Islands Fisheries Science Center (US), National Wildlife Health Center (US), New York State College of Veterinary Medicine (US), Marine Mammal Commission (US), University of Glasgow (GB)
Openalex Percentile: Top 7%
Zoonotic diseases and public health
3.26
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.